Preoperative CEA, NSE, SCC, TPA and CYFRA 21.1 serum levels as prognostic indicators in resected non-small cell lung cancer

Paolo Foa, M. Fornier, R. Miceli, E. Seregni, L. Santambrogio, M. Nosotti, S. Massaron, I. Cataldo, S. Oldani, A. Iurlo, S. Caldiera, E. Bombardieri

Research output: Contribution to journalArticle

Abstract

In 62 patients affected by resectable non-small cell lung cancer (NSCLC) submitted to radical surgery, we evaluated the prognostic significance of CEA, NSE, SCC, TPA and CYFRA 21.1 serum levels at diagnosis, as well as the predictive ability of these tumor markers with respect to histological type and pathological stage. The group was composed of 56 male and 6 female patients; the median age was 62 years (range 29-73 years). Thirty-four patients had a histological diagnosis of adenocarcinoma and 28 of squamous cell carcinoma; with regard to pathological stage, 32 patients had stage I, 4 patients stage II and 23 patients stage IIIA disease. A good predictive ability with respect to histological type was obtained with SCC serum levels; as for pathological stage, TPA and CYFRA 21.1 were found to have moderate predictive ability. In this series of patients, at a median follow-up of 55 months after surgery we found that both TPA and CYFRA 21.1 serum levels at diagnosis were reliable predictors of overall survival, high values of these markers being associated with a worse prognosis.

Original languageEnglish
Pages (from-to)92-98
Number of pages7
JournalInternational Journal of Biological Markers
Volume14
Issue number2
Publication statusPublished - Apr 1999

    Fingerprint

Keywords

  • CEA
  • CYFRA 21.1
  • Non-small cell lung cancer
  • NSE
  • SCC
  • TPA

ASJC Scopus subject areas

  • Immunology
  • Biochemistry

Cite this